MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors
Tumors, Neoplasm Metastasis
About this trial
This is an interventional treatment trial for Tumors focused on measuring Advanced metastatic or solid tumors
Eligibility Criteria
Inclusion Criteria: Diagnosis of progressive advanced or metastatic (tumor that has spread) solid tumors No tumor spread to the brain Feeling well other than cancer diagnosis (i.e. lab work, no infection, etc.) Available tumor tissue sample from prior surgery 4-6 weeks since prior therapy and recovered from prior therapy Men and women, ages 18 and above Women must not be pregnant or breastfeeding Diagnosis of advanced or metastatic (tumor that has spread) colorectal, hepatocellular (liver) or renal (kidney) cancer Measurable disease on scans (at least one)
Sites / Locations
- Premiere Oncology
- Indiana University Med Center
- University Of Wisconsin Comprehensive Center
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
1
2
3
4
5
6